Acacia Pharma announces supportive cardiac safety data BARHEMSYS™
Company news Acacia Pharma Group plc have announced results from its latest study of BARHEMSYS (intravenous amisulpride), its anti-emetic currently under...
Read MoreDisposable Bronchoscope now available from CMS
Promotional feature Central Medical Supplies (CMS) has been chosen by medical device company Axess Vision Technology as the sole UK...
Read MoreMen and women remember pain differently
Scientists increasingly believe that one of the driving forces in chronic pain – the number one health problem in both...
Read MoreRerouting nerves during amputation reduces phantom limb pain before it starts
Doctors at The Ohio State University Wexner Medical Center and College of Medicine are pioneering the use of primary targeted...
Read MoreBrain activity predicts fear of pain
Researchers applied a machine learning technique that could potentially translate patterns of activity in fear-processing brain regions into scores on...
Read MoreAn insight into the global anaesthesia laryngeal masks market 2018-2022
The global anaesthesia laryngeal masks market is expected to post a CAGR of over 6 per cent during the period...
Read MoreAcacia Pharma announces positive BARHEMSYS ™ rescue treatment data
Acacia Pharma Group plc announces that data and analyses from its positive Phase 3 clinical trial of BARHEMSYS™ (intravenous amisulpride)...
Read More‘Waltzing’ nanoparticles could advance search for better drug delivery methods
Indiana University researchers have discovered that drug-delivering nanoparticles attach to their targets differently based upon their position when they meet....
Read More